发布于: 公告转发:1回复:1喜欢:0
$Medpace控股(MEDP)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026595 Size: 837 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

全部讨论

Revenue of $214.1 million in the second quarter of 2019 increased 25.8% from revenue of $170.1 million for the comparable prior-year period, representing a backlog conversion rate of 19.3%.

Net new business awards were $279.2 million in the second quarter of 2019, representing an increase of 16.4% from net new business awards of $239.9 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 1.30x.

Second quarter of 2019 GAAP net income was $27.5 million, or $0.73 per diluted share, versus GAAP net income of $16.6 million, or $0.45 per diluted share, for the comparable prior-year period. Net income margin was 12.8% and 9.7% for the second quarter of 2019 and 2018, respectively.

EBITDA was $40.2 million for the second quarter of 2019, an increase of 20.3% from EBITDA of $33.4 million for the comparable prior-year period, resulting in an EBITDA margin of 18.8%.

Adjusted Net Income was $30.4 million, or $0.81 per diluted share, for the second quarter of 2019, an increase of 35.7% from the comparable prior-year period.